Jeffrey PharmD - Nutriband Chief Officer
| NTRB Stock | USD 4.77 0.10 2.05% |
Insider
Jeffrey PharmD is Chief Officer of Nutriband
| Age | 54 |
| Address | 121 South Orange Avenue, Orlando, FL, United States, 32801 |
| Phone | 407 377 6695 |
| Web | https://nutriband.com |
Nutriband Management Efficiency
The company has return on total asset (ROA) of (0.3588) % which means that it has lost $0.3588 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7308) %, meaning that it created substantial loss on money invested by shareholders. Nutriband's management efficiency ratios could be used to measure how well Nutriband manages its routine affairs as well as how well it operates its assets and liabilities. As of May 24, 2024, Return On Tangible Assets is expected to decline to -3.15. In addition to that, Return On Capital Employed is expected to decline to -0.78. At present, Nutriband's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 11.6 K, whereas Total Assets are forecasted to decline to about 5.5 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Carol Odle | Revelation Biosciences | N/A | |
| Cameron Shaw | Virax Biolabs Group | 37 | |
| Professor MD | Allarity Therapeutics | 67 | |
| Timur Dogan | Cardio Diagnostics Holdings | 36 | |
| John CPA | Unicycive Therapeutics | 62 | |
| Jason Davis | Virax Biolabs Group | 52 | |
| MD DrSc | Allarity Therapeutics | 81 | |
| Claus Pedersen | Allarity Therapeutics | 52 | |
| PharmD BCPS | Neurobo Pharmaceuticals | N/A | |
| MPA MD | Unicycive Therapeutics | 51 | |
| James Foster | Virax Biolabs Group | 39 | |
| Annie Rasmussen | Allarity Therapeutics | 67 | |
| James Rolke | Revelation Biosciences | 55 | |
| Frank Kondrad | Neurobo Pharmaceuticals | N/A | |
| James JD | Allarity Therapeutics | 55 | |
| Ben MD | Neurobo Pharmaceuticals | 68 | |
| Tomasz George | Virax Biolabs Group | 40 | |
| Steen Knudsen | Allarity Therapeutics | 63 | |
| MBA JD | Cardio Diagnostics Holdings | 60 | |
| Chester III | Revelation Biosciences | 44 | |
| Joan Brown | Allarity Therapeutics | 70 | |
Management Performance
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.36 |
Nutriband Leadership Team
Elected by the shareholders, the Nutriband's board of directors comprises two types of representatives: Nutriband inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nutriband. The board's role is to monitor Nutriband's management team and ensure that shareholders' interests are well served. Nutriband's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nutriband's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patrick Ryan, Chief Technical Officer | ||
| Tyler Overk, President Intelligence | ||
| Gerald Goodman, CFO Officer | ||
| Alan Smith, Head of 4P Therapeutics and Clinical Development | ||
| Serguei Melnik, President, Founder | ||
| Gareth Sheridan, CEO, Director | ||
| Jeffrey PharmD, Chief Officer |
Nutriband Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nutriband a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.36 | ||||
| Profit Margin | (2.63) % | ||||
| Operating Margin | (2.49) % | ||||
| Current Valuation | 52.03 M | ||||
| Shares Outstanding | 10.97 M | ||||
| Shares Owned By Insiders | 44.00 % | ||||
| Shares Owned By Institutions | 2.31 % | ||||
| Number Of Shares Shorted | 19.35 K | ||||
| Price To Earning | (15.98) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| GM | General Motors | |
| CRM | Salesforce |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutriband. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Nutriband Stock refer to our How to Trade Nutriband Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Nutriband Stock analysis
When running Nutriband's price analysis, check to measure Nutriband's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutriband is operating at the current time. Most of Nutriband's value examination focuses on studying past and present price action to predict the probability of Nutriband's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutriband's price. Additionally, you may evaluate how the addition of Nutriband to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Nutriband's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nutriband. If investors know Nutriband will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nutriband listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.262 | Quarterly Revenue Growth (0.01) | Return On Assets (0.36) | Return On Equity (0.73) |
The market value of Nutriband is measured differently than its book value, which is the value of Nutriband that is recorded on the company's balance sheet. Investors also form their own opinion of Nutriband's value that differs from its market value or its book value, called intrinsic value, which is Nutriband's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nutriband's market value can be influenced by many factors that don't directly affect Nutriband's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nutriband's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nutriband is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nutriband's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.